43.46
전일 마감가:
$43.17
열려 있는:
$43.27
하루 거래량:
11,892
Relative Volume:
0.31
시가총액:
$229.97M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.37%
1개월 성능:
+3.37%
6개월 성능:
-3.10%
1년 성능:
+3.62%
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
XPH을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
XPH
Spdr Pharmaceuticals Etf
|
43.46 | 229.97M | 0 | 0 | 0 | 0.00 |
![]()
VTI
Vanguard Total Stock Market Etf
|
312.49 | 417.53B | 0 | 0 | 0 | 0.00 |
![]()
SPY
Spdr S P 500 Etf Trust
|
636.04 | 372.57B | 0 | 0 | 0 | 0.00 |
![]()
IVV
Ishares Core S P 500 Etf
|
639.24 | 253.41B | 0 | 0 | 0 | 0.00 |
![]()
VB
Vanguard Small Cap Etf
|
239.53 | 160.59B | 0 | 0 | 0 | 0.00 |
![]()
QQQ
Invesco Qqq Trust Series 1
|
573.25 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf 주식(XPH)의 최신 뉴스
Mark Cuban Says Cutting PBM Fees Won't Reduce… - inkl
SPDR Dow Jones REIT ETF (NYSEARCA:RWR) Shares Bought by Cwm LLC - Defense World
BREAKING: Surprise FDA Exit May Boost Biotech ETF XBI - AInvest
Palantir, Nvidia & Tempus AI: The Future of Medicine in 2025 - AInvest
6 Best Health Care Funds and ETFs for 2025 | Investing - Money/ US News
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again - MSN
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - MSN
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Benzinga
XPH: Healthcare Dashboard For July (NYSEARCA:XPH) - Seeking Alpha
(XPH) Technical Data - news.stocktradersdaily.com
SA Quant's top healthcare picks amid Q2 earnings season - MSN
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - Benzinga
The Tariff Tipping Point: Navigating Copper and Pharma Markets in an Era of Trade Rigidity - AInvest
U.S. Tariffs on Copper and Pharmaceuticals: Navigating Sector Shifts and Portfolio Risks - AInvest
Trump's Tariff Tsunami: Navigating Copper Gains and Pharma Headwinds - AInvest
Trading (XPH) With Integrated Risk Controls - news.stocktradersdaily.com
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' - Yahoo Finance
Global pharma stocks down as Trump renews tariff threat - MSN
Wealthcare Advisory Partners LLC Takes $339,000 Position in SPDR SSgA Ultra Short Term Bond ETF (NYSEARCA:ULST) - Defense World
Short bets on S&P 500 Healthcare sector ease in May; MRNA stays most shorted stock - MSN
Kalkine Reports Surge in SPDR S&P 500 Pharma ETF Trading Activity - Kalkine Media
Friday's ETF with Unusual Volume: XPH - Nasdaq
Cetera Investment Advisers Sells 718 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Ameriprise Financial Inc. Decreases Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
2,299 Shares in SPDR S&P Aerospace & Defense ETF (NYSEARCA:XAR) Purchased by D. E. Shaw & Co. Inc. - Defense World
Invesco S&P 500 Pure Growth ETF (NYSEARCA:RPG) Stake Boosted by Ameriprise Financial Inc. - Defense World
D. E. Shaw & Co. Inc. Has $363,000 Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
D. E. Shaw & Co. Inc. Decreases Holdings in SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) - Defense World
Bank of America Corp DE Sells 22,425 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Navigating Geopolitical Storms: How Sector ETFs Can Turn Volatility into Opportunity - AInvest
Trump Sparks New Chapter In Transatlantic Trade War: What The US Buys From Europe - Benzinga
Captrust Financial Advisors Increases Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
SPDR S&P International Small Cap ETF (NYSEARCA:GWX) Shares Sold by Focus Partners Wealth - Defense World
1,953 Shares in SPDR S&P Semiconductor ETF (NYSEARCA:XSD) Acquired by Focus Partners Wealth - Defense World
US health authorities to set targets for lowering drug prices - Reuters
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work - inkl
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Short bets against S&P 500 healthcare stocks climb in April; MRNA retains top shorted ranking - MSN
A Silent Crash Inside S&P’s Good Day - Forbes
Stock ETFs Surge on China Tariffs Pact; Bonds, Gold Falter - Yahoo Finance
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks - Benzinga
A Look at Pharma ETFs After Strong Q1 Earnings - Yahoo Finance
Raymond James Financial Inc. Invests $762,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
SPDR S&P 400 Mid Cap Value ETF (NYSEARCA:MDYV) Shares Bought by Renaissance Technologies LLC - Defense World
Spdr Pharmaceuticals Etf (XPH) 재무 분석
Spdr Pharmaceuticals Etf (XPH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):